IMARA  logo
IMARA IMRA

Annual report 2025
added 03-03-2026

report update icon

IMARA Shares 2011-2026 | IMRA

Annual Shares IMARA

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
56.7 M 47.1 M 35.5 M 3.12 M 21.7 M 17.2 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
56.7 M 3.12 M 30.2 M

Quarterly Shares IMARA

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
62.1 M 52.1 M 50.1 M 48.9 M 48.3 M 48.1 M 42 M 41.3 M 41 M 41 M 41 M 3.57 M 3.23 M 3.1 M 2.88 M 26.3 M 24.9 M 17.7 M 17.6 M 17.5 M 17.3 M 17.2 M 3.49 M 703 K 703 K 703 K 703 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
62.1 M 703 K 24.9 M

Shares of other stocks in the Biotechnology industry

Issuer Shares Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
33.4 M - 2.43 % $ 254 M germanyGermany
Biohaven Pharmaceutical Holding Company Ltd. Biohaven Pharmaceutical Holding Company Ltd.
BHVN
64.7 M $ 9.83 2.5 % $ 636 M usaUSA
BioNTech SE BioNTech SE
BNTX
244 M $ 98.36 -4.92 % $ 27.2 B germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
10.2 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
220 M - - $ 866 M chinaChina
Akero Therapeutics Akero Therapeutics
AKRO
67.1 M - - $ 3.67 B usaUSA
Burford Capital Limited Burford Capital Limited
BUR
219 M $ 5.12 4.07 % $ 820 M britainBritain
Midatech Pharma plc Midatech Pharma plc
MTP
80.5 M - -18.52 % $ 27.3 M britainBritain
AlloVir AlloVir
ALVR
15.3 M - 4.14 % $ 49.1 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
219 M - - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
118 M - -13.47 % $ 169 M franceFrance
Genfit SA Genfit SA
GNFT
44.7 B - 2.54 % $ 160 B franceFrance
Cerus Corporation Cerus Corporation
CERS
191 M $ 2.57 26.6 % $ 490 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
166 M $ 21.92 -2.38 % $ 3.63 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
4.58 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
4.28 M - - $ 269 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
38.8 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
15.4 M - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
1.42 B - - $ 96.9 B britainBritain
Atreca Atreca
BCEL
38.6 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
68.9 M - -7.31 % $ 87 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
73.9 M - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
6.02 M - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
106 M - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
69.9 K - - $ 3.74 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
75 M - - - russiaRussia
Caladrius Biosciences Caladrius Biosciences
CLBS
8.33 M - -16.75 % $ 25.8 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
21.6 M - - $ 231 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
115 M - 5.93 % $ 314 M canadaCanada
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
9.27 M - -2.5 % $ 5.88 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
66.8 M $ 1.74 0.29 % $ 116 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
78.2 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
45 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
85.1 M - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
14.3 M - 1.93 % $ 17.4 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
130 M - - $ 2.02 B usaUSA
Akouos Akouos
AKUS
34.4 M - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
86.8 M - - $ 28.6 M usaUSA
Editas Medicine Editas Medicine
EDIT
88.7 M $ 2.91 -3.17 % $ 258 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
3.2 M $ 17.93 -1.86 % $ 57.3 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
1.65 M $ 2.95 -7.52 % $ 4.86 M israelIsrael
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
1.48 M - -9.21 % $ 2.55 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
2.17 M - -5.68 % $ 8.28 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
186 M - - $ 867 M germanyGermany
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
810 K - -11.43 % $ 502 K usaUSA
Applied Therapeutics Applied Therapeutics
APLT
84.2 M - - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
2.45 M - -45.71 % $ 1.2 M canadaCanada
Evogene Ltd. Evogene Ltd.
EVGN
40.4 M $ 0.78 - $ 27.9 M israelIsrael
Aptinyx Aptinyx
APTX
67.7 M - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
36.4 M - -13.39 % $ 1.45 M usaUSA